Hypogonadism, Male clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • EndoPAT Device for Endothelial Dysfunction in ED

    Sorry, not yet accepting patients

    To assess endothelial dysfunction in young men (aged 30-50) with vasculogenic ED identified through penile Doppler ultrasound. To evaluate changes in endothelial function using EndoPAT before and 3-6 months after daily low-dose phosphodiesterase type 5 (PDE5) inhibitor therapy. To investigate endothelial function alterations in hypogonadal patients before and 3-6 months after initiating testosterone (T) therapy

    at UC Irvine

Our lead scientists for Hypogonadism, Male research studies include .

Last updated: